{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:37:43Z","timestamp":1783201063163,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/pr.2014.20","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T17:01:33Z","timestamp":1392138093000},"page":"626-630","source":"Crossref","is-referenced-by-count":11,"title":["Serum brain-type creatine kinase increases in children with osteogenesis imperfecta during neridronate treatment"],"prefix":"10.1038","volume":"75","author":[{"given":"Patrizia","family":"D\u2019Eufemia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Finocchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lodato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Palombaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Properzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Celli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,11]]},"reference":[{"key":"BFpr201420_CR1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00726-011-0877-3","volume":"40","author":"T Wallimann","year":"2011","unstructured":"Wallimann T, Tokarska-Schlattner M, Schlattner U . The creatine kinase system and pleiotropic effects of creatine. Amino Acids 2011;40:1271\u201396.","journal-title":"Amino Acids"},{"key":"BFpr201420_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/biof.5520080310","volume":"8","author":"T Wallimann","year":"1998","unstructured":"Wallimann T, Dolder M, Schlattner U, et al. Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors 1998;8:229\u201334.","journal-title":"Biofactors"},{"key":"BFpr201420_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/bj2810021","volume":"281 (Pt 1)","author":"T Wallimann","year":"1992","unstructured":"Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM . Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the \u2018phosphocreatine circuit\u2019 for cellular energy homeostasis. Biochem J 1992;281 (Pt 1):21\u201340.","journal-title":"Biochem J"},{"key":"BFpr201420_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1357-2725(01)00142-X","volume":"34","author":"MJ Francis","year":"2002","unstructured":"Francis MJ, Lees RL, Trujillo E, Mart\u00edn-Vasallo P, Heersche JN, Mobasheri A . ATPase pumps in osteoclasts and osteoblasts. Int J Biochem Cell Biol 2002;34:459\u201376.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFpr201420_CR5","doi-asserted-by":"publisher","first-page":"e5030","DOI":"10.1371\/journal.pone.0005030","volume":"4","author":"JW Kuiper","year":"2009","unstructured":"Kuiper JW, van Horssen R, Oerlemans F, et al. Local ATP generation by brain-type creatine kinase (CK-B) facilitates cell motility. PLoS One 2009;4:e5030.","journal-title":"PLoS One"},{"key":"BFpr201420_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nm.1860","volume":"14","author":"EJ Chang","year":"2008","unstructured":"Chang EJ, Ha J, Oerlemans F, et al. Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nat Med 2008;14:966\u201372.","journal-title":"Nat Med"},{"key":"BFpr201420_CR7","first-page":"3615","volume":"285","author":"J Chen","year":"2010","unstructured":"Chen J, Sun Y, Mao X, Liu Q, Wu H, Chen Y . Rankl up-regulates brain-type creatine kinase via poly (ADP-ribose) polymerase-1 during osteoclastogenesis. J Biol Chem 2010;285:3615\u201321.","journal-title":"J Biol Chem"},{"key":"BFpr201420_CR8","first-page":"1284","volume":"320","author":"T Yoneyama","year":"1989","unstructured":"Yoneyama T, Fowler HL, Pendleton JW, et al. Elevated levels of creatine kinase BB isoenzyme in three patients with adult osteopetrosis. N Engl J Med 1989;320:1284\u20135.","journal-title":"N Engl J Med"},{"key":"BFpr201420_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/BF02556458","volume":"48","author":"J Gram","year":"1991","unstructured":"Gram J, Antonsen S, H\u00f8rder M, Bollerslev J . Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II. Calcif Tissue Int 1991;48:438\u20139.","journal-title":"Calcif Tissue Int"},{"key":"BFpr201420_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1399-0004.1992.tb03134.x","volume":"42","author":"T Yoneyama","year":"1992","unstructured":"Yoneyama T, Fowler HL, Pendleton JW, et al. Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II\u2013a family study. Clin Genet 1992;42:39\u201342.","journal-title":"Clin Genet"},{"key":"BFpr201420_CR11","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/jbmr.5650111010","volume":"11","author":"MP Whyte","year":"1996","unstructured":"Whyte MP, Chines A, Silva DP Jr, Landt Y, Ladenson JH . Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders. J Bone Miner Res 1996;11:1438\u201343.","journal-title":"J Bone Miner Res"},{"key":"BFpr201420_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/NEJMoa023110","volume":"349","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S . Bisphosphonate-induced osteopetrosis. N Engl J Med 2003;349:457\u201363.","journal-title":"N Engl J Med"},{"key":"BFpr201420_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH . Osteogenesis imperfecta. Lancet 2004;363:1377\u201385.","journal-title":"Lancet"},{"key":"BFpr201420_CR14","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/S0140-6736(01)07058-1","volume":"358","author":"FH Glorieux","year":"2001","unstructured":"Glorieux FH . Osteogenesis imperfecta. A disease of the osteoblast. Lancet 2001;358:S45.","journal-title":"Lancet"},{"key":"BFpr201420_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00228-012-1216-7","volume":"68","author":"N Maruotti","year":"2012","unstructured":"Maruotti N, Corrado A, Neve A, Cantatore FP . Bisphosphonates: effects on osteoblast. Eur J Clin Pharmacol 2012;68:1013\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"BFpr201420_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ . Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008;19:733\u201359.","journal-title":"Osteoporos Int"},{"key":"BFpr201420_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","volume":"18","author":"S Adami","year":"2003","unstructured":"Adami S, Gatti D, Colapietro F, et al. Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res 2003;18:126\u201330.","journal-title":"J Bone Miner Res"},{"key":"BFpr201420_CR18","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1359\/jbmr.080511","volume":"23","author":"MP Whyte","year":"2008","unstructured":"Whyte MP, McAlister WH, Novack DV, Clements KL, Schoenecker PL, Wenkert D . Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases. J Bone Miner Res 2008;23:1698\u2013707.","journal-title":"J Bone Miner Res"},{"key":"BFpr201420_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2165\/00002018-199614030-00003","volume":"14","author":"S Adami","year":"1996","unstructured":"Adami S, Zamberlan N . Adverse effects of bisphosphonates. A comparative review. Drug Saf 1996;14:158\u201370.","journal-title":"Drug Saf"},{"key":"BFpr201420_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/07853890510007386","volume":"37","author":"F Rauch","year":"2005","unstructured":"Rauch F, Glorieux FH . Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long? Ann Med 2005;37:295\u2013302.","journal-title":"Ann Med"},{"key":"BFpr201420_CR21","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/j.1651-2227.2010.01968.x","volume":"99","author":"E Astr\u00f6m","year":"2010","unstructured":"Astr\u00f6m E, Magnusson P, Eksborg S, S\u00f6derh\u00e4ll S . Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta. Acta Paediatr 2010;99:1834\u201340.","journal-title":"Acta Paediatr"},{"key":"BFpr201420_CR22","first-page":"3049","volume":"124","author":"M Li","year":"2011","unstructured":"Li M, Xia WB, Xing XP, et al. Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta. Chin Med J (Engl) 2011;124:3049\u201353.","journal-title":"Chin Med J (Engl)"},{"key":"BFpr201420_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM . Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16:101\u201316.","journal-title":"J Med Genet"},{"key":"BFpr201420_CR24","unstructured":"IFCC Primary reference procedures for the measurements of catalytic activity concentration of enzymes at 37\u00b0C. Part 2: reference procedure for the measurements of catalytic concentration of creatine kinase. Clin Chem Lab Med 2002;40:635\u201342."},{"key":"BFpr201420_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0009-8981(68)90023-5","volume":"21","author":"TD Trainer","year":"1968","unstructured":"Trainer TD, Gruenig D . A rapid method for the analysis of creatine phosphokinase isoenzymes. Clin Chim Acta 1968;21:151\u20134.","journal-title":"Clin Chim Acta"},{"key":"BFpr201420_CR26","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1210\/jc.2011-1111","volume":"96","author":"BS Zemel","year":"2011","unstructured":"Zemel BS, Kalkwarf HJ, Gilsanz V, et al. Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 2011;96:3160\u20139.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201420","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T05:02:04Z","timestamp":1684472524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFpr201420"],"URL":"https:\/\/doi.org\/10.1038\/pr.2014.20","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,11]]}}}